Weight loss reduces breast cancer risk, the mechanisms of which are still poorly understood. As an effective therapy for obesity, bariatric surgery may be a powerful tool in breast cancer prevention and treatment. This review details the potential physiologic mechanisms that may underlie this ...
In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions. We present the conclusions in this Review. First we agreed that the term chemoprevention is inappropriate and suggested that the...
cancer incidence, as well as cancer related morbidity and mortality, are constantly increasing, especially for developing countries and for breast and prostate cancer, the predominant gender-associated cancer types. In addition to continuing, with more and more expensive efforts to develop...
Breast Cancer Treatment (PDQ®)—Health Professional Version. National Cancer Institute. Accessed April 10, 2024. https://www.cancer.gov/types/breast/hp/breast-treatment-pdq 16. Alvidrez J, Castille D, Laude-Sharp M, Rosario A, Tabor D. The National Institute on Minority...
Phase 1a - patients who completed treatment for early-stage,triple-negative breast cancerwithin the past three years and are currently tumor-free but at high risk for recurrence. Phase 1b - individuals who are cancer-free and at high risk for developing breast cancer who have elected to volunt...
Breast cancer (BC) is known as the most prevalent form of cancer among women. Recent research has demonstrated the potential of Machine Learning (ML) techn
Funded by the US Department of Defense, the new study at Cleveland Clinic will include 18 to 24 patients who have completed treatment for early-stage triple-negative breast cancer within the past three years and are currently tumor-free but at high risk for recurrence. During the course of th...
Younger Patients With Breast Cancer Have Unique Needs, Concerns Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd Advancing the Standard of Breast Cancer Treatment With CDK4/6 Inhibitors Pattie Jakel Highlights the Challenges With Oral Therapies in Breast Cancer Kara Morris an...
The present invention provides (1) an agent for the prevention or treatment of an estrogen receptor-negative and HER2-negative breast cancer comprising an Akt inhibitor, (2) an agent for the prevention or treatment of an estrogen recepto... S Umemura,Y Tokuda,S Yoshida,... - US 被引量:...
Globally, breast cancer is not only the most frequently diagnosed cancer but also the leading cause of cancer death in women. Depending on breast cancer histotype, conventional breast cancer treatment options vary greatly in efficacy and accompanying side effects. Thus, there is a need for more ...